Search results for "tumor response rate"

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage. Patients with refractory—or treatment-resistant—Crohn’s...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs

A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Complete Remission in Metastatic Pancreatic Cancer: Nesuparib Shows Early Clinical Promise

Early clinical data point to extended survival and the rare possibility of complete remission in metastatic pancreatic...
Re-evaluating the Knife: Why Some Thyroid Cancers No Longer Require Immediate Surgery

Re-evaluating the Knife: Why Some Thyroid Cancers No Longer Require Immediate Surgery

During a routine health screening, a doctor points out a small lump on your thyroid. Additional tests deliver a jarring...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Walking 30 Minutes a Day May Lower Breast Cancer Risk in Young Women

Walking 30 Minutes a Day May Lower Breast Cancer Risk in Young Women

A new study reports that walking for just 30 minutes a day can create an anticancer environment in the blood and...
Why Young Colorectal Cancer Rates are Surging in Korea: The Paradox of “High-Quality” Protein

Why Young Colorectal Cancer Rates are Surging in Korea: The Paradox of “High-Quality” Protein

The common refrain "you have to eat meat to have strength" reflects a cultural sentiment in Korea that is anything but...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...